Cargando…

GOLPH3 is a novel marker of poor prognosis and a potential therapeutic target in human renal cell carcinoma

BACKGROUND: Golgi phosphoprotein 3 (GOLPH3) has been reported to be involved in the development of several human cancers. The present study was conducted to investigate the expression of GOLPH3 and its prognostic significance in renal cell carcinoma (RCC). Meanwhile, the function of GOLPH3 in human...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xue, Y, Wu, G, Liao, Y, Xiao, G, Ma, X, Zou, X, Zhang, G, Xiao, R, Wang, X, Liu, Q, Long, D, Yang, J, Xu, H, Liu, F, Liu, M, Xie, K, Huang, R
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2014
Materias:	Molecular Diagnostics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4007226/ https://www.ncbi.nlm.nih.gov/pubmed/24595000 http://dx.doi.org/10.1038/bjc.2014.124

Ejemplares similares

High leukocyte mitochondrial DNA content contributes to poor prognosis in glioma patients through its immunosuppressive effect
por: Chen, Y, et al.
Publicado: (2015)

Id-1 and Id-2 are markers for metastasis and prognosis in oesophageal squamous cell carcinoma
por: Yuen, H-F, et al.
Publicado: (2007)

GOLPH2 protein expression as a novel tissue biomarker for prostate cancer: implications for tissue-based diagnostics
por: Kristiansen, G, et al.
Publicado: (2008)

P2Y2 receptor promotes cell invasion and metastasis in prostate cancer cells
por: Li, W-H, et al.
Publicado: (2013)

RAD21 cohesin overexpression is a prognostic and predictive marker exacerbating poor prognosis in KRAS mutant colorectal carcinomas
por: Deb, S, et al.
Publicado: (2014)

Golgi phosphoprotein 2 (GOLPH2) is a novel bile acid-responsive modulator of oesophageal cell migration and invasion
por: Byrne, Anne-Marie, et al.
Publicado: (2015)

Notch1 activation is a poor prognostic factor in patients with gastric cancer
por: Zhang, H, et al.
Publicado: (2014)

Metadherin regulates proliferation and metastasis via actin cytoskeletal remodelling in non-small cell lung cancer
por: Yao, Y, et al.
Publicado: (2014)

MiR-646 inhibited cell proliferation and EMT-induced metastasis by targeting FOXK1 in gastric cancer
por: Zhang, P, et al.
Publicado: (2017)

Serum microRNA-210 as a potential noninvasive biomarker for the diagnosis and prognosis of glioma
por: Lai, N-s, et al.
Publicado: (2015)

Tumoral CD105 is a novel independent prognostic marker for prognosis in clear-cell renal cell carcinoma
por: Saroufim, A, et al.
Publicado: (2014)

Serum 20S proteasome is elevated in patients with renal cell carcinoma and associated with poor prognosis
por: de Martino, M, et al.
Publicado: (2012)

Amplification of PVT-1 is involved in poor prognosis via apoptosis inhibition in colorectal cancers
por: Takahashi, Y, et al.
Publicado: (2014)

Polypeptide N-acetylgalactosaminyl transferase 3 independently predicts high-grade tumours and poor prognosis in patients with renal cell carcinomas
por: Kitada, S, et al.
Publicado: (2013)

Nucleostemin mRNA is expressed in both normal and malignant renal tissues
por: Fan, Y, et al.
Publicado: (2006)

High-level expression of Rad51 is an independent prognostic marker of survival in non-small-cell lung cancer patients
por: Qiao, G-B, et al.
Publicado: (2005)

Characterisation of a novel cell line (CSQT-2) with high metastatic activity derived from portal vein tumour thrombus of hepatocellular carcinoma
por: Wang, T, et al.
Publicado: (2010)

Cancer-associated fibroblasts induce epithelial–mesenchymal transition of breast cancer cells through paracrine TGF-β signalling
por: Yu, Y, et al.
Publicado: (2014)

TBLR1 is a novel prognostic marker and promotes epithelial–mesenchymal transition in cervical cancer
por: Wang, J, et al.
Publicado: (2014)

Downregulated miR-646 in clear cell renal carcinoma correlated with tumour metastasis by targeting the nin one binding protein (NOB1)
por: Li, W, et al.
Publicado: (2014)

Predictive value of miR-9 as a potential biomarker for nasopharyngeal carcinoma metastasis
por: Lu, J, et al.
Publicado: (2014)

COUP-TFII regulates metastasis of colorectal adenocarcinoma cells by modulating Snail1
por: Bao, Y, et al.
Publicado: (2014)

Isolation of tumour stem-like cells from benign tumours
por: Xu, Q, et al.
Publicado: (2009)

Serpin peptidase inhibitor clade A member 1 is a biomarker of poor prognosis in gastric cancer
por: Kwon, C H, et al.
Publicado: (2014)

Endoplasmic reticulum ribosome-binding protein 1, RRBP1, promotes progression of colorectal cancer and predicts an unfavourable prognosis
por: Pan, Y, et al.
Publicado: (2015)

High expression of TROP2 correlates with poor prognosis in pancreatic cancer
por: Fong, D, et al.
Publicado: (2008)

Leucine-rich repeat-containing G-protein-coupled receptor 5 is associated with invasion, metastasis, and could be a potential therapeutic target in human gastric cancer
por: Xi, H Q, et al.
Publicado: (2014)

Two-marker protein profile predicts poor prognosis in patients with early rectal cancer
por: Zlobec, I, et al.
Publicado: (2008)

IGFBP7 is associated with poor prognosis in oesophageal adenocarcinoma and is regulated by promoter DNA methylation
por: Smith, E, et al.
Publicado: (2014)

High expression of Lin28 is associated with tumour aggressiveness and poor prognosis of patients in oesophagus cancer
por: Hamano, R, et al.
Publicado: (2012)

Expression of carbonic anhydrase 9, a potential intrinsic marker of hypoxia, is associated with poor prognosis in oesophageal squamous cell carcinoma
por: Tanaka, N, et al.
Publicado: (2008)

FMNL2 destabilises COMMD10 to activate NF-κB pathway in invasion and metastasis of colorectal cancer
por: Yang, S S, et al.
Publicado: (2017)

MicroRNA-100/99a, deregulated in acute lymphoblastic leukaemia, suppress proliferation and promote apoptosis by regulating the FKBP51 and IGF1R/mTOR signalling pathways
por: Li, X-J, et al.
Publicado: (2013)

Response in bone turnover markers during therapy predicts overall survival in patients with metastatic prostate cancer: analysis of three clinical trials
por: Som, A, et al.
Publicado: (2012)

The FOXD3/miR-214/MED19 axis suppresses tumour growth and metastasis in human colorectal cancer
por: He, G Y, et al.
Publicado: (2016)

Oncogenic CXCL10 signalling drives metastasis development and poor clinical outcome
por: Wightman, S C, et al.
Publicado: (2015)

Perivascular PDGFR-β is an independent marker for prognosis in renal cell carcinoma
por: Frödin, Magnus, et al.
Publicado: (2017)

A nanomaterial-based breath test for distinguishing gastric cancer from benign gastric conditions
por: Xu, Z-q, et al.
Publicado: (2013)

MicroRNA profiling in clear cell renal cell carcinoma tissues potentially links tumorigenesis and recurrence with obesity
por: Shu, X, et al.
Publicado: (2017)

Arpin downregulation in breast cancer is associated with poor prognosis
por: Lomakina, Maria E, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_lfepin7moi18suumqa7t7jcc36